VENTOLIN HFA- albuterol sulfate aerosol, metered United States - English - NLM (National Library of Medicine)

ventolin hfa- albuterol sulfate aerosol, metered

a-s medication solutions - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - ventolin hfa inhalation aerosol is indicated for the treatment or prevention of bronchospasm in patients aged 4 years and older with reversible obstructive airway disease. ventolin hfa is indicated for the prevention of exercise-induced bronchospasm in patients aged 4 years and older. ventolin hfa is contraindicated in patients with a history of hypersensitivity to any of the ingredients [see warnings and precautions (5.6), description (11)] . teratogenic effects pregnancy category c. there are no adequate and well-controlled trials with ventolin hfa or albuterol sulfate in pregnant women. during worldwide marketing experience, various congenital anomalies, including cleft palate and limb defects, have been reported in the offspring of patients being treated with albuterol. some of the mothers were taking multiple medications during their pregnancies. no consistent pattern of defects can be discerned, and a relationship between albuterol use and congenital anomalies has not been established. animal reproducti

VENTOLIN HFA- albuterol sulfate aerosol, metered United States - English - NLM (National Library of Medicine)

ventolin hfa- albuterol sulfate aerosol, metered

a-s medication solutions - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - ventolin hfa is indicated for the treatment or prevention of bronchospasm in adult and pediatric patients aged 4 years and older with reversible obstructive airway disease. ventolin hfa is indicated for the prevention of exercise-induced bronchospasm in adult and pediatric patients aged 4 years and older. ventolin hfa is contraindicated in patients with a history of hypersensitivity to any of the ingredients [see warnings and precautions (5.6), description (11)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to asthma medications during pregnancy. for more information, contact the mothertobaby pregnancy studies conducted by the organization of teratology information specialists at 1‑877-311-8972 or visit https://mothertobaby.org/ongoing-study/asthma/. risk summary there are no randomized clinical studies of use of albuterol sulfate during pregnancy. available data from epidemiological studies and postmarketing case reports of pregnancy ou